Apoptosis Research

The article on apoptosis by Ricki Lewis (The Scientist, Feb. 6, 1995, page 15) contains a number of significant errors and omissions. The fact that bcl-2 specifically blocks cell death was first demonstrated in 1988 (D.L. Vaux et al., Nature, 335:440-2), and this was confirmed by others two years later (D. Hockenbery et al., Nature, 348:334-6, 1990). At that stage, the sequence of none of the C. elegans ced genes had been published, so bcl-2 was the first apoptosis regulatory gene known in any

Written byDavid Vaux
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article on apoptosis by Ricki Lewis (The Scientist, Feb. 6, 1995, page 15) contains a number of significant errors and omissions. The fact that bcl-2 specifically blocks cell death was first demonstrated in 1988 (D.L. Vaux et al., Nature, 335:440-2), and this was confirmed by others two years later (D. Hockenbery et al., Nature, 348:334-6, 1990). At that stage, the sequence of none of the C. elegans ced genes had been published, so bcl-2 was the first apoptosis regulatory gene known in any species.

Work on apoptosis in mammalian cells and programmed cell death in C. elegans proceeded independently, until it was demonstrated in 1992 that human bcl-2 could block ced-3/ced-4 mediated cell death in C. elegans (D.L. Vaux et al., Science, 258:1955-57). This experiment showed for the first time that apoptosis in mammalian cells and programmed cell death in the nematode were one and the same process, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies